BioticsAI FDA Clearance for AI Fetal Abnormality Detection Software
BioticsAI has secured FDA clearance for its AI-powered fetal abnormality detection software. The 2023 TechCrunch Disrupt winner aims to combat U.S. maternal health disparities through automation.
The U.S. faces a growing maternal health crisis with some of the worst outcomes among high-income nations. Now, BioticsAI, the winner of TechCrunch Disrupt Battlefield 2023, is deploying its computer vision technology to the front lines after receiving FDA clearance for its fetal abnormality detection software.
Scaling BioticsAI FDA Clearance for Maternal Health
The software is designed to support fetal ultrasound quality assessment and automated reporting. CEO Robhy Bustami, who grew up in a family of obstetricians, founded the company in 2021 to address the frequent misdiagnoses caused by low-quality ultrasound images.
In an environment where disparities in healthcare outcomes are well documented, it was critical to demonstrate consistent performance across patient subgroups.
Key Specs and Availability
| Feature | Detail |
|---|---|
| Core Technology | Computer Vision AI for Ultrasound |
| Training Data | Hundreds of thousands of diverse scans |
| FDA Process Time | Under 3 years |
| Target Launch | Nationwide health systems in 2026 |
| Price | Price Undisclosed (B2B) |
BioticsAI's next focus is scaling across various health systems nationwide. The team also plans to deepen the technology's power by adding more features for reproductive health and fetal medicine.
Authors
Related Articles
Elon Musk promised minds merged with AI. Neuralink delivered a brain-controlled cursor. The gap between the two reveals something important about how Silicon Valley sells the future.
From period trackers to newborn blood samples, the data our bodies generate is being harvested, sold, and subpoenaed. A deep look at who benefits—and who pays the price.
Since FDA approval in 2022, the hearing aid market has transformed dramatically. Low-cost alternatives are disrupting traditional medical devices, sparking an accessibility revolution.
Fitbit founders James Park and Eric Friedman launch Luffu, an AI-powered family health platform that shifts focus from individual tracking to coordinated family caregiving.
Elon Musk promised minds merged with AI. Neuralink delivered a brain-controlled cursor. The gap between the two reveals something important about how Silicon Valley sells the future.
From period trackers to newborn blood samples, the data our bodies generate is being harvested, sold, and subpoenaed. A deep look at who benefits—and who pays the price.
Since FDA approval in 2022, the hearing aid market has transformed dramatically. Low-cost alternatives are disrupting traditional medical devices, sparking an accessibility revolution.
Fitbit founders James Park and Eric Friedman launch Luffu, an AI-powered family health platform that shifts focus from individual tracking to coordinated family caregiving.
Thoughts
Share your thoughts on this article
Sign in to join the conversation